News

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Teladoc Health Inc (Symbol: TDOC), where a total of 27,377 contracts have traded so far, representing approximately 2.7 million underlying shares. That amounts to about 67.1% of TDOC's average daily trading volume over the past month of 4.1 million shares. Especially high volume was seen for the $10.50 strike call option expiring January 24, 2025, with 3,812 contracts trading so far today, representing approximately 381,200 underlying shares of TDOC. Below is a chart showing TDOC's trailing twelve month trading history, with the $10.50 strike highlighted in orange:

Travere Therapeutics Inc (Symbol: TVTX) saw options trading volume of 7,542 contracts, representing approximately 754,200 underlying shares or approximately 60.6% of TVTX's average daily trading volume over the past month, of 1.2 million shares. Especially high volume was seen for the $20 strike call option expiring March 21, 2025, with 2,054 contracts trading so far today, representing approximately 205,400 underlying shares of TVTX. Below is a chart showing TVTX's trailing twelve month trading history, with the $20 strike highlighted in orange:

And CVS Health Corporation (Symbol: CVS) saw options trading volume of 85,306 contracts, representing approximately 8.5 million underlying shares or approximately 59.4% of CVS's average daily trading volume over the past month, of 14.4 million shares. Especially high volume was seen for the $54 strike call option expiring January 24, 2025, with 17,218 contracts trading so far today, representing approximately 1.7 million underlying shares of CVS. Below is a chart showing CVS's trailing twelve month trading history, with the $54 strike highlighted in orange:

For the various different available expirations for TDOC options, TVTX options, or CVS options, visit StockOptionsChannel.com.

Also see:

Cheap Stocks With Potential
POOL MACD
AVTA shares outstanding history

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.